VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
HYPRHyperfine, Inc.
$1.60$135M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

HYPR logoHyperfine, Inc.(HYPR)Earnings, Financials & Key Ratios

HYPR•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryImaging, radiation, and oncology devices
AboutHyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.Show more
  • Revenue$14M+5.2%
  • EBITDA-$35M+17.4%
  • Net Income-$36M+12.6%
  • EPS (Diluted)-0.43+23.2%
  • Gross Margin49.79%+8.9%
  • EBITDA Margin-257.2%+21.5%
  • Operating Margin-273.43%+18.5%
  • Net Margin-262.29%+17.0%
  • ROE-79.01%-29.5%

HYPR Key Insights

Hyperfine, Inc. (HYPR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Momentum leader: RS Rating 82 (top 18%)
  • ✓Strong 5Y sales CAGR of 115.2%

✗Weaknesses

  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow
  • ✗Shares diluted 30.1% in last year
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when HYPR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

HYPR Price & Volume

Hyperfine, Inc. (HYPR) stock price & volume — 10-year historical chart

Loading chart...

HYPR Growth Metrics

Hyperfine, Inc. (HYPR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years115.18%
3 Years25.79%
TTM30.66%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM13.68%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM23.56%

Return on Capital

10 Years-57.89%
5 Years-57.4%
3 Years-62.86%
Last Year-79.16%

HYPR Recent Earnings

Hyperfine, Inc. (HYPR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 12, 2026
Metric
Actual
Est
EPS
$0.09+0.0%
$0.09
Rev
$4M+10.3%
$4M
Q2 2026
Mar 18, 2026
Metric
Actual
Est
EPS
$0.08+0.0%
$0.08
Rev
$5M+2.7%
$5M
Q4 2025
Nov 13, 2025
Metric
Actual
Est
EPS
$0.11-10.0%
$0.10
Rev
$3M-35.2%
$5M
Q3 2025
Aug 13, 2025
Metric
Actual
Est
EPS
$0.12+0.0%
$0.12
Rev
$3M-10.1%
$3M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 12, 2026
$0.09vs $0.09+0.0%
$4Mvs $4M+10.3%
Q2 2026Mar 18, 2026
$0.08vs $0.08+0.0%
$5Mvs $5M+2.7%
Q4 2025Nov 13, 2025
$0.11vs $0.10-10.0%
$3Mvs $5M-35.2%
Q3 2025Aug 13, 2025
$0.12vs $0.12+0.0%
$3Mvs $3M-10.1%
Based on last 12 quarters of dataView full earnings history →

HYPR Peer Comparison

Hyperfine, Inc. (HYPR) competitors in Imaging, radiation, and oncology devices — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
PRCT logoPRCTPROCEPT BioRobotics CorporationDirect Competitor1.24B21.72-12.6337.22%-31.82%-27.7%0.14
NVCR logoNVCRNovoCure LimitedDirect Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85
INVA logoINVAInnoviva, Inc.Direct Competitor1.66B22.496.8218.52%118.91%47.59%0.23
AEYE logoAEYEAudioEye, Inc.Direct Competitor78.83M6.31-25.2414.52%-9.05%-70.95%2.75
GEHC logoGEHCGE HealthCare Technologies Inc.Product Competitor28.02B61.5913.544.84%7.54%14.45%0.94
SYK logoSYKStryker CorporationProduct Competitor117.88B307.8036.6411.16%12.92%15.04%0.66
IRTC logoIRTCiRhythm Technologies, Inc.Product Competitor3.44B104.65-75.2926.24%-3.53%-20.6%4.79
INSP logoINSPInspire Medical Systems, Inc.Product Competitor1.23B42.618.7113.6%14.33%17.98%0.04

Compare HYPR vs Peers

Hyperfine, Inc. (HYPR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PRCT

Most directly comparable listed peer for HYPR.

Scale Benchmark

vs NVDA

Larger-name benchmark to compare HYPR against a more recognizable public peer.

Peer Set

Compare Top 5

vs PRCT, NVCR, INVA, AEYE

HYPR Income Statement

Hyperfine, Inc. (HYPR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
0294K1.5M6.81M11.03M12.89M13.56M15.33M
Revenue Growth %
--408.84%355.48%61.9%16.84%5.22%30.66%
Cost of Goods Sold
0771K2.66M5.91M6.28M7M6.81M7.48M
COGS % of Revenue
-262.24%178.01%86.69%56.88%54.3%50.21%-
Gross Profit
0▲ 0%
-477K▲ 0%
-1.17M▼ 144.7%
907K▲ 177.7%
4.76M▲ 424.5%
5.89M▲ 23.8%
6.75M▲ 14.6%
7.85M▲ 0%
Gross Margin %
--162.24%-78.01%13.31%43.12%45.7%49.79%51.2%
Gross Profit Growth %
---144.65%177.72%424.48%23.84%14.63%-
Operating Expenses
19.97M23.01M63.7M74.78M52.87M49.12M43.84M42.59M
OpEx % of Revenue
-7827.89%4258.09%1097.46%479.26%381.03%323.22%-
Selling, General & Admin
6.58M8.42M37.86M46.63M30.38M26.62M26.39M26.33M
SG&A % of Revenue
-2864.29%2530.68%684.25%275.37%206.49%194.55%-
Research & Development
13.39M14.59M25.84M28.16M22.49M22.5M17.45M16.26M
R&D % of Revenue
-4963.61%1727.41%413.21%203.89%174.55%128.67%-
Other Operating Expenses
00000000
Operating Income
-19.97M▲ 0%
-23.49M▼ 17.6%
-64.87M▼ 176.1%
-73.87M▼ 13.9%
-48.12M▲ 34.9%
-43.22M▲ 10.2%
-37.09M▲ 14.2%
-34.74M▲ 0%
Operating Margin %
--7990.14%-4336.1%-1084.15%-436.14%-335.33%-273.43%-226.64%
Operating Income Growth %
--17.64%-176.14%-13.88%34.87%10.17%14.2%-
EBITDA
-19.83M-23.2M-64.14M-72.86M-47.06M-42.22M-34.88M-33.19M
EBITDA Margin %
--7891.84%-4287.57%-1069.25%-426.59%-327.5%-257.2%-216.52%
EBITDA Growth %
--17.02%-176.45%-13.59%35.41%10.3%17.37%21.91%
D&A (Non-Cash Add-back)
141K289K726K1.01M1.05M1.01M2.2M1.55M
EBIT
-19.97M-23.49M-64.87M-73.87M-48.12M-43.22M-37.09M-36.47M
Net Interest Income
630K70K18K761K3.84M2.49M1.02M877K
Interest Income
630K70K18K761K3.84M2.49M1.02M960K
Interest Expense
000000083K
Other Income/Expense
553K64K17K710K3.88M2.5M1.51M-38K
Pretax Income
-19.41M▲ 0%
-23.43M▼ 20.7%
-64.85M▼ 176.8%
-73.16M▼ 12.8%
-44.24M▲ 39.5%
-40.72M▲ 8.0%
-35.57M▲ 12.6%
-34.78M▲ 0%
Pretax Margin %
--7968.37%-4334.96%-1073.73%-401%-315.9%-262.29%-226.88%
Income Tax
00000000
Effective Tax Rate %
0%0%0%0%0%0%0%0%
Net Income
-18.79M▲ 0%
-23.36M▼ 24.3%
-64.83M▼ 177.6%
-73.16M▼ 12.8%
-44.24M▲ 39.5%
-40.72M▲ 8.0%
-35.57M▲ 12.6%
-34.78M▲ 0%
Net Margin %
--7944.56%-4333.76%-1073.73%-401%-315.9%-262.29%-226.88%
Net Income Growth %
--24.34%-177.57%-12.85%39.54%7.95%12.64%13.68%
Net Income (Continuing)
-19.41M-23.43M-64.85M-73.16M-44.24M-40.72M-35.57M-34.78M
Discontinued Operations
00000000
Minority Interest
00000000
EPS (Diluted)
-4.06▲ 0%
-0.93▲ 77.1%
-0.92▲ 1.1%
-1.04▼ 13.0%
-0.62▲ 40.4%
-0.56▲ 9.7%
-0.43▲ 23.2%
-0.36▲ 0%
EPS Growth %
-77.09%1.08%-13.04%40.38%9.68%23.21%23.56%
EPS (Basic)
-4.06-0.93-0.92-1.04-0.62-0.56-0.43-
Diluted Shares Outstanding
4.62M25.2M70.33M70.45M71.32M72.41M94.2M97.7M
Basic Shares Outstanding
4.62M25.2M70.33M70.45M71.32M72.41M94.2M97.7M
Dividend Payout Ratio
--------

HYPR Balance Sheet

Hyperfine, Inc. (HYPR) balance sheet — assets, liabilities & shareholders' equity

MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
27.96M68.33M197.49M128.66M88.91M53.71M50.91M56.03M
Cash & Short-Term Investments
26.44M62.68M188.5M118.24M75.18M37.65M35.09M40.78M
Cash Only
26.44M62.68M188.5M118.24M75.18M37.65M35.09M40.78M
Short-Term Investments
00000000
Accounts Receivable
0174K644K3.13M4.13M8.3M6.52M5.8M
Days Sales Outstanding
-216.02157.13167.66136.68235.17175.52152.25
Inventory
01.72M4.31M4.62M6.58M5.83M7.09M6.33M
Days Inventory Outstanding
-813.32590.74285.6382.86304.14380.01294.45
Other Current Assets
683K3.54M2.87M2.67M3.01M1.93M2.21M3.13M
Total Non-Current Assets
2.61M3.19M4.99M5.39M5.29M5.19M4.35M4.31M
Property, Plant & Equipment
489K1.9M3.75M3.25M3M3.12M2.55M56.03M
Fixed Asset Turnover
-0.15x0.40x2.10x3.68x4.13x5.32x0.95x
Goodwill
00000000
Intangible Assets
00000000
Long-Term Investments
000744K0825K734K1.67M
Other Non-Current Assets
2.12M1.29M1.24M1.4M2.29M1.24M1.07M-51.73M
Total Assets
30.57M▲ 0%
71.53M▲ 134.0%
202.47M▲ 183.1%
134.05M▼ 33.8%
94.2M▼ 29.7%
58.9M▼ 37.5%
55.26M▼ 6.2%
60.34M▲ 0%
Asset Turnover
-0.00x0.01x0.05x0.12x0.22x0.25x0.30x
Asset Growth %
-133.97%183.08%-33.79%-29.73%-37.47%-6.18%-74.26%
Total Current Liabilities
1.79M4.12M15.74M8.8M8.77M8.73M11.73M10.15M
Accounts Payable
1.19M948K2.25M678K1.21M1.61M4.05M4.55M
Days Payables Outstanding
-448.79308.1241.8970.6283.81217.12186.45
Short-Term Debt
000000248K0
Deferred Revenue (Current)
00730K1.38M2.07M1.49M1.54M5.93M
Other Current Liabilities
107K1.79M700K2.2M2.91M473K5.89M4.02M
Current Ratio
15.63x16.60x12.55x14.62x10.14x6.15x4.34x5.52x
Quick Ratio
15.63x16.18x12.28x14.09x9.39x5.48x3.73x4.90x
Cash Conversion Cycle
-580.55439.75411.37448.92455.5338.4260.25
Total Non-Current Liabilities
0178K510K1.53M1.03M1.13M2.52M15.82M
Long-Term Debt
0178K000000
Capital Lease Obligations
00000066K78K
Deferred Tax Liabilities
00000000
Other Non-Current Liabilities
010064K78K1.73M15.82M
Total Liabilities
1.79M4.29M16.25M10.33M9.8M9.86M14.26M25.98M
Total Debt
0178K00185K269K314K0
Net Debt
-26.44M-62.5M-188.5M-118.24M-75M-37.38M-34.77M-40.78M
Debt / Equity
-0.00x--0.00x0.01x0.01x0.00x
Debt / EBITDA
--------0.00x
Net Debt / EBITDA
-------1.23x
Interest Coverage
--------439.40x
Total Equity
28.78M▲ 0%
67.23M▲ 133.6%
186.23M▲ 177.0%
123.72M▼ 33.6%
84.4M▼ 31.8%
49.04M▼ 41.9%
41.01M▼ 16.4%
34.36M▲ 0%
Equity Growth %
-133.59%176.99%-33.56%-31.78%-41.89%-16.38%-138%
Book Value per Share
6.222.672.651.761.180.680.440.35
Total Shareholders' Equity
28.78M67.23M186.23M123.72M84.4M49.04M41.01M34.36M
Common Stock
007K7K7K7K10K10K
Retained Earnings
-48.04M-71.47M-136.32M-209.48M-253.72M-294.44M-330.02M-338.64M
Treasury Stock
00000000
Accumulated OCI
00000000
Minority Interest
00000000

HYPR Cash Flow Statement

Hyperfine, Inc. (HYPR) cash flow — operating, investing & free cash flow history

MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-18.37M-21.52M-47.18M-72.34M-41.81M-38.77M-27.95M-27.71M
Operating CF Margin %
--7321.43%-3153.88%-1061.62%-378.98%-300.75%-206.06%-
Operating CF Growth %
--17.16%-119.2%-53.32%42.2%7.28%27.91%90.46%
Net Income
-19.41M-23.43M-64.85M-73.16M-44.24M-40.72M-35.57M-34.78M
Depreciation & Amortization
141K289K726K1.01M1.05M1.01M1.09M1.38M
Stock-Based Compensation
896K1.12M6.9M10.65M4.74M4.36M2.8M1.86M
Deferred Taxes
00000000
Other Non-Cash Items
4K169K1.07M91K249K204K-677K1.6M
Working Capital Changes
2K327K8.97M-10.93M-3.62M-3.62M4.41M2.23M
Change in Receivables
309K-956K981K-1.55M-1.57M-2.77M1.78M1.47M
Change in Inventory
-651K-1.93M-2.67M-312K-2.21M562K-1.48M-1.91M
Change in Payables
467K-377K1.44M-1.57M533K382K2.43M2.33M
Cash from Investing
-244K-1.57M-2.71M-585K-804K-383K-1.19M-955K
Capital Expenditures
-244K-1.57M-2.71M-585K-804K-383K-1.19M-955K
CapEx % of Revenue
-533.33%181.22%8.59%7.29%2.97%8.74%6.23%
Acquisitions
00000000
Investments
--------
Other Investing
00000000
Cash from Financing
4.74M60.94M176.77M7K174K1.02M27.5M36.41M
Debt Issued (Net)
-1M178K-178K000013.64M
Equity Issued (Net)
059.77M30.47M7K174K848K27.5M22.77M
Dividends Paid
00000000
Share Repurchases
00000000
Other Financing
5.74M991K146.48M00171K00
Net Change in Cash
-13.88M▲ 0%
37.84M▲ 372.7%
126.87M▲ 235.2%
-72.92M▼ 157.5%
-42.44M▲ 41.8%
-38.13M▲ 10.2%
-1.63M▲ 95.7%
7.74M▲ 0%
Free Cash Flow
-18.62M▲ 0%
-23.09M▼ 24.0%
-49.89M▼ 116.1%
-72.92M▼ 46.2%
-42.61M▲ 41.6%
-39.15M▲ 8.1%
-29.13M▲ 25.6%
-28.66M▲ 0%
FCF Margin %
--7854.76%-3335.09%-1070.21%-386.27%-303.72%-214.8%-186.98%
FCF Growth %
--24.05%-116.05%-46.16%41.57%8.13%25.59%20.86%
FCF per Share
-4.03-0.92-0.71-1.04-0.60-0.54-0.31-0.29
FCF Conversion (FCF/Net Income)
0.98x0.92x0.73x0.99x0.95x0.95x0.79x0.82x
Interest Paid
06K000000
Taxes Paid
00000000

HYPR Key Ratios

Hyperfine, Inc. (HYPR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric202020212022202320242025TTM
Return on Equity (ROE)
-48.65%-51.16%-47.21%-42.51%-61.03%-79.01%-101.28%
Return on Invested Capital (ROIC)
-498.04%-3950.55%-3454.21%-485.03%-307.79%-310.8%-691.09%
Gross Margin
-162.24%-78.01%13.31%43.12%45.7%49.79%51.2%
Net Margin
-7944.56%-4333.76%-1073.73%-401%-315.9%-262.29%-226.88%
Debt / Equity
0.00x--0.00x0.01x0.01x0.00x
Interest Coverage
-------439.40x
FCF Conversion
0.92x0.73x0.99x0.95x0.95x0.79x0.82x
Revenue Growth
-408.84%355.48%61.9%16.84%5.22%30.66%
Related:HYPR Dividend History·HYPR Revenue History·HYPR Price History·HYPR P/E History·HYPR Financial Ratios·HYPR Institutional Holders

HYPR SEC Filings & Documents

Hyperfine, Inc. (HYPR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 21, 2026·SEC

Material company update

May 12, 2026·SEC

Material company update

Mar 18, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 18, 2026·SEC

FY 2025

Mar 17, 2025·SEC

FY 2024

Mar 22, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 12, 2026·SEC

FY 2025

Nov 13, 2025·SEC

FY 2025

Aug 13, 2025·SEC

HYPR Frequently Asked Questions

Hyperfine, Inc. (HYPR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Hyperfine, Inc. (HYPR) reported $15.3M in revenue for fiscal year 2025.

Hyperfine, Inc. (HYPR) grew revenue by 5.2% over the past year. This is steady growth.

Hyperfine, Inc. (HYPR) reported a net loss of $34.8M for fiscal year 2025.

Dividend & Returns

Hyperfine, Inc. (HYPR) has a return on equity (ROE) of -79.0%. Negative ROE indicates the company is unprofitable.

Hyperfine, Inc. (HYPR) had negative free cash flow of $28.7M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in HYPR back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →

How much would $100/month in HYPR be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →